Pays: Royaume-Uni
Langue: anglais
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Risperidone
Actavis UK Ltd
N05AX08
Risperidone
500microgram
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 04020100; GTIN: 5012617015723
* Please note that ONLY Artwork Studio is permitted to make changes to the above artwork. No changes are permitted by any 3rd party other than added notes and mark ups for required changes. approved for print/date PROOF ROUND UK-Eire-Artwork-Support@accord-healthcare.com Technical Approval NON PRINTING COLOURS COLOURS DATE SENT: DATE RECEIVED: Item number: ORIGINATOR: ORIGINATION DATE: REVISION DATE: REVISED BY: DIMENSIONS: MIN BODY TEXT SIZE: SUPPLIER: 1. 2. 3. 4. 5. 6. 1. 2. 3. FMD info NA (not a carton) No Yes Details RISPERIDONE 0.5MG, 1MG, 2MG, 3MG & 4MG TABLETS PIL - UK Black BBBA1810 S.Anson 15.03.18 19.03.18 S.Anson 190 x 380 7pt Actavis Bulgaria Dupnitsa 15.03.18 16.03.18 2 Version 2 01.11.2017 PACKAGE LEAFLET: INFORMATION FOR THE USER RISPERIDONE 0.5MG, 1MG, 2MG, 3MG, AND 4MG FILM-COATED TABLETS BBBA1810 _Continued over page_ _Continued top of next column_ READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1 WHAT RISPERIDONE TABLETS ARE AND WHAT THEY ARE USED FOR 2 WHAT YOU NEED TO KNOW BEFORE YOU TAKE RISPERIDONE TABLETS 3 HOW TO TAKE RISPERIDONE TABLETS 4 POSSIBLE SIDE EFFECTS 5 HOW TO STORE RISPERIDONE TABLETS 6 CONTENTS OF THE PACK AND OTHER INFORMATION 1 WHAT RISPERIDONE TABLETS ARE AND WHAT THEY ARE USED FOR Risperidone Tablets belong to a group of medicines called ‘anti-psychotics’. Risperidone Tablets are used to treat the following: • Schizophrenia, where you may see, hear or feel things that are not there, believe things that are not true or feel unusually susp Lire le document complet
OBJECT 1 RISPERIDONE 0.5MG FILM-COATED TABLETS Summary of Product Characteristics Updated 16-Apr-2018 | Accord-UK Ltd 1. Name of the medicinal product Risperidone 0.5mg Film-coated Tablets 2. Qualitative and quantitative composition Each tablet contains 0.5mg of the active substance risperidone. Excipient with known effect: 61.70mg lactose monohydrate per tablet. For the full list of excipients, see section 6.1 3. Pharmaceutical form Film coated Tablet Light yellow, 8 x 5mm, oval, biconvex, scored, coated tablets, marking T. 4. Clinical particulars 4.1 Therapeutic indications Risperidone tablets is indicated for the treatment of schizophrenia. Risperidone tablets is indicated for the treatment of moderate to severe manic episodes associated with bipolar disorders. Risperidone tablets is indicated for the short-term treatment (up to 6 weeks) of persistent aggression in patients with moderate to severe Alzheimer's dementia unresponsive to non-pharmacological approaches and when there is a risk of harm to self or others. Risperidone tablets is indicated for the short-term symptomatic treatment (up to 6 weeks) of persistent aggression in conduct disorder in children from the age of 5 years and adolescents with subaverage intellectual functioning or mental retardation diagnosed according to DSM-IV criteria, in whom the severity of aggressive or other disruptive behaviours require pharmacologic treatment. Pharmacological treatment should be an integral part of a more comprehensive treatment programme, including psychosocial and educational intervention. It is recommended that risperidone be prescribed by a specialist in child neurology and child and adolescent psychiatry or physicians well familiar with the treatment of conduct disorder of children and adolescents. 4.2 Posology and method of administration Posology Schizophrenia _Adults_ Risperidone tablets may be given once daily or twice daily. Patients should start with 2 mg/day risperidone. The dosage may be increased on the second day to 4 mg. Subsequently, th Lire le document complet